HIV-1 Nef-mediated T-cell activation and chemotaxis are decoupled using a HIV-1/SIVpbj1.9. chimeric nef variant

Arch Virol. 2013 Apr;158(4):845-52. doi: 10.1007/s00705-012-1560-z. Epub 2012 Dec 7.

Abstract

HIV-1 Nef is known to activate CD4+ T cells but inhibit their migration toward SDF-1α. However, it is not clear how this protein orchestrates these two seemingly concomitant events. In this study, by comparing these two activities of HIV-1 Nef with those of its primate counterpart, SIVpbj1.9, we found that HIV-1 Nef activated T cells only in the presence of CD3/ CD28 stimulation, while SIVpbj1.9 Nef did even without CD3/CD28. We also observed that HIV-1 Nef inhibited T-cell chemotaxis toward SDF-1α, while SIVpbj1.9 Nef did not. A hybrid between HIV-1 and SIVpbj1.9 Nef completely abrogated the chemotaxis blockade by HIV-1 Nef while failing to activate T cells without CD3/CD28 co-stimulation. Mutations in the myristoylation and SH3-binding site, but not the basic-rich domain, in Nef were unresponsive to CD3/CD28 stimulation but reversed the inhibition of migration. These findings indicate that the signals for T-cell activation by Nef do not necessarily parallel those for T-cell migration.

MeSH terms

  • CD28 Antigens / immunology
  • CD3 Complex / immunology
  • Chemotaxis, Leukocyte / immunology
  • Enzyme-Linked Immunosorbent Assay / methods
  • Gene Expression Regulation, Viral
  • Genetic Variation
  • HIV-1 / genetics*
  • HIV-1 / immunology
  • Humans
  • Interleukin-2 / genetics
  • Interleukin-2 / metabolism
  • Jurkat Cells
  • Lymphocyte Activation / physiology
  • Simian Immunodeficiency Virus / genetics*
  • Simian Immunodeficiency Virus / physiology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / physiology*
  • T-Lymphocytes / virology
  • nef Gene Products, Human Immunodeficiency Virus / genetics*
  • nef Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • CD28 Antigens
  • CD3 Complex
  • Interleukin-2
  • nef Gene Products, Human Immunodeficiency Virus